Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

Show other versions (1)
Bibliographic Details
Main Authors: Emanuel Ferreira, Nuno Oliveira, Maria Marques, Luís Francisco, Ana Santos, Armando Carreira, Mário Campos
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:Nefrología (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2013251416000079

Internet

http://www.sciencedirect.com/science/article/pii/S2013251416000079

Similar Items